These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6422944)

  • 1. 3-N-substituted-amino-1-[3-(trifluoromethyl)phenyl]-2-pyrazolines have enhanced activity against arachidonate 5-lipoxygenase and cyclooxygenase.
    Copp FC; Islip PJ; Tateson JE
    Biochem Pharmacol; 1984 Jan; 33(2):339-40. PubMed ID: 6422944
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of some 3-amino-2-pyrazoline derivatives on cyclooxygenase and lipoxidase activities.
    Robak J; Duniec Z
    Biochem Pharmacol; 1982 Jun; 31(11):1955-9. PubMed ID: 6810898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug.
    Hidaka T; Takeo K; Hosoe K; Katsumi I; Yamashita T; Watanabe K
    Jpn J Pharmacol; 1985 Jul; 38(3):267-72. PubMed ID: 3932730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mononuclear leukocyte accumulation by the arachidonic acid lipoxygenase inhibitor BW755C.
    Higgs GA; Mugridge KG
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():19-23. PubMed ID: 6221592
    [No Abstract]   [Full Text] [Related]  

  • 5. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
    Boctor AM; Burke C; Hovinga ME
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of putative inhibitors on cytosolic and membrane associated platelet lipoxygenase.
    Rao GH; Kishore NP; White JG
    Prostaglandins Leukot Med; 1987 Mar; 26(3):281-90. PubMed ID: 3106988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple procedure for measuring the pharmacodynamics and analgesic potential of lipoxygenase inhibitors.
    Carey F; Haworth D; Edmonds AE; Forder RA
    J Pharmacol Methods; 1988 Dec; 20(4):347-56. PubMed ID: 3145369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antirheumatics and inhibitors of cyclooxygenase, lipoxygenases and thromboxane synthetase on cobra venom factor rat paw edema.
    Otto M; Bekemeier H; Hirschelmann R
    Biomed Biochim Acta; 1984; 43(8-9):S291-5. PubMed ID: 6440543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory properties of lipoxygenase products and the effects of indomethacin and BW755C on prostaglandin production, leukocyte migration, and plasma exudation in rabbit skin.
    Higgs GA; Bax CM; Moncada S
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():331-9. PubMed ID: 6211959
    [No Abstract]   [Full Text] [Related]  

  • 10. Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro.
    Boctor AM; Eickholt M; Pugsley TA
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):229-38. PubMed ID: 3020588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo.
    Beetens JR; Loots W; Somers Y; Coene MC; De Clerck F
    Biochem Pharmacol; 1986 Mar; 35(6):883-91. PubMed ID: 3006695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies into cyclo-oxygenase, lipoxygenase and phospholipase in smooth muscle contraction in the isolated trachea.
    Mitchell HW
    Br J Pharmacol; 1984 Jul; 82(3):549-55. PubMed ID: 6430374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free radical scavenging properties of modulators of eicosanoid metabolism.
    Slater TF; Cheeseman KH; Davies MJ; Hayashi M; Sharma OP; Nigam S; Benedetto C
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():1098-102. PubMed ID: 2960152
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization.
    Metz SA
    Endocrinology; 1987 Jun; 120(6):2534-46. PubMed ID: 3106021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.
    Prosiegel M; Neu I; Mallinger J; Wildfeuer A; Mehlber L; Vogl S; Hoffmann G; Ruhenstroth-Bauer G
    Acta Neurol Scand; 1989 Mar; 79(3):223-6. PubMed ID: 2541593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone releasing factor (GRF) increases free arachidonate levels in the pituitary: a role for lipoxygenase products.
    Canonico PL; Speciale C; Sortino MA; Cronin MJ; MacLeod RM; Scapagnini U
    Life Sci; 1986 Jan; 38(3):267-72. PubMed ID: 2867452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses.
    Higgs GA; Follenfant RL; Garland LG
    Br J Pharmacol; 1988 Jun; 94(2):547-51. PubMed ID: 2840161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do inhibitors of lipoxygenase and cyclooxygenase block neonatal hypoxic pulmonary vasoconstriction?
    Cassin S; Gause G; Davis T; ter Riet M; Baker R
    J Appl Physiol (1985); 1989 Apr; 66(4):1779-84. PubMed ID: 2499569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lipoxygenase inhibitors on release of slow-reacting substances from human lung.
    Armour CL; Hughes JM; Seale JP; Temple DM
    Eur J Pharmacol; 1981 Jun; 72(1):93-6. PubMed ID: 6167455
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of steroid production in Leydig cells by non-steroidal anti-inflammatory and related compounds: evidence for the involvement of lipoxygenase products in steroidogenesis.
    Dix CJ; Habberfield AD; Sullivan MH; Cooke BA
    Biochem J; 1984 Apr; 219(2):529-37. PubMed ID: 6430271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.